BioMed X and Merck extend research collaboration

The two entered a partnership in 2013 and the resulting research has led to 25 scientific publications

picture of

Breaking News

CN Bio licenses gut modelling tool from MIT

The GuMi device was licensed by Professor Linda Griffith at MIT's Department of Biological Engineering and joint patent- ...

Nanopharm and Leyden Labs to develop nasal sprays for virus protection

Leyden Labs’ platform targets commonalities of viral families to develop candidates that protect against many strains ...

Stablepharma partners with University of Strathclyde on StablevaX tech

The WHO estimates that up to 50% of all vaccines manufactured currently lose their efficacy before they can be delivered

Oncolytic viruses: the key to advancing novel therapies to market

As researchers continue to uncover and understand the enormous complexities of cancer, emerging technology and novel ...

Aptamer partners with pharma company on vaccine development

The global pharmaceutical company will use Aptamer’s Optimer reagents to support the development of a vaccine ...

BioMed X and Merck launch oncology research programme

The key aim of the project will be to generate a comprehensive atlas of extrachromosomal DNA in human cancer tissues

Using ddPCR to accurately quantify AAV viral titre and integrity

Gene therapy is primed to become the next major development in medicine and bring relief to patients living with ...

Protagen Protein Services merges with GeneWerk

The move establishes a premier, protein and gene analytic testing service platform worldwide

LegoChem and Iksuda expand ADC license agreement

In April 2020, Iksuda licensed global development and commercialisation rights for three ADC programmes using LCB's ADC ...

Lab standardisation: working smarter to improve patient outcomes

We’re living in a pivotal time for healthcare, reports Benjamin Lilienfeld, LifeCycle Leader at Roche Diagnostics ...

Opportunities to scale AAV viral vector production for gene therapies

Gene therapies hold tremendous potential as a treatment modality for inherited human diseases. This emerging ...

Humans, hybrid models and the power of collaboration: part II

Dr Kevin Robinson recently spoke to Diane Diehl, Senior Director of Scientific Operations at Waters Corp., to discover ...

PMI and TissUse collaborate on human aerosol test platform

The companies aim to combine their complementary technologies and expertise

DeepMatter collaborates with universities on manufacturing

The company will provide its DigitalGlassware software, a cloud-based platform that allows chemists to share data in ...